T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid(Harvard University), Michael S. Goldberg(Dana-Farber Cancer Institute)
Cited by 440
Related Papers
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer
|Journal for ImmunoTherapy of Cancer|2019|36